Oura is syncing with Dexcom.
Done deal. The smart ring maker landed $75M from the medical device company, reaching a $5B+ valuation.
The partnership will integrate Dexcom’s glucose monitoring data with Oura’s health-tracking platform to boost CGM and smart ring sales.
All-access. Expanding beyond sleep and activity data, Oura recently acquired metabolic health startup Veri to help users decode food’s impact on well-being.
Meanwhile, Dexcom began selling its Stelo glucose sensor over the counter, making it the first device available without a prescription.
Teaming up, the pair plans to roll out data sharing next year, bringing awareness to nutrition’s role in overall health.
Fast track. Riding momentum from its Gen 4 ring launch, M&A efforts, and partnership push, Oura is projecting $500M in revenue for 2024, double last year’s numbers.
Looking ahead: The glucose monitoring market is heating up, with Apple and Samsung exploring tracking tech. Linking with Dexcom, Oura could have an edge as wearable makers eye medical device status.
